Biogen says goodbye to Aduhelm

The latest stories trending on MedCity News.

Editor's Pick

Top Story Biogen Says Goodbye to Beleaguered Alzheimer's Drug Aduhelm Biogen has returned its Aduhelm rights to Neurimmune, the company that initially developed the antibody Alzheimer's disease drug. But Biogen isn't abandoning Alzheimer's, and its pipeline includes drugs that take other approaches to the neurodegenerative disorder. Did You See Who's Speaking at INVEST 2024? World-renowned cardiologist Dr. Henry Ting, who is currently the Senior Vice President, Chief Health & Wellness Officer, Delta Air Lines, and Adjunct Professor of Medicine, Emory University, and Professor Emeritus, Mayo Clinic. See him May 21-22 in Chicago. You can still save with the super early pricing until February 16th. Reserve Your Seat Now

Featured News

ACO REACH Challenging to Succeed in First Year But Tools Can Help To succeed in ACO Reach, groups need to accurately identify the social determinants of health (SDoH) barriers affecting their patient population and determine which barriers could be addressed effectively. Some technology can accurately note specific SDoH risk factors facing a given patient and offer targeted intervention recommendations based on that patient's unique SDoH risk factors. Mental Health Startup Combining Psychiatry with Novel Treatments Launches with $5.4M in Funding Being Health, a startup that launched last week, offers a care team that includes psychiatrists, psychotherapists, nurse anesthetists, functional medicine physicians, nutritionists, acupuncturists and care advocates. It serves patients both virtually and in person. Transforming Diagnosis and Treatment of Pediatric Pneumonia Through Point-Of-Care Lung Ultrasound Point-of-care lung ultrasound – also known as lung POCUS – is a safer, more reliable alternative to X-ray in diagnosing pneumonia that provides information quickly. Yet it's not widely considered the standard of care. We've Actually Treated Tens of Thousands of People on Ozempic to Date - Here's What Really Happens and What It Likely Means for Solving Our Obesity Epidemic We and our collective organizations' providers have treated 10,000's of Americans, who suffer from obesity and/or Type 2 diabetes with GLP-1 drugs. And we believe we have important observations to share. Healthcare Moves: A Monthly Summary of Hires and Layoffs Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

Resources

How To Enable a Hyperpersonal Care Experience This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe